West Pharmaceutical Services (WST) Exchange Rate Effect (2009 - 2026)

West Pharmaceutical Services has disclosed Exchange Rate Effect across 18 years of filings, most recently posting -$8.4 million for Q1 2026.

• Exchange Rate Effect for Q1 2026 came in at -$8.4 million, down 198.82% year-over-year; the trailing twelve-month figure through Mar 2026 was $6.0 million (up 242.86% YoY), and the FY2025 annual result was $22.9 million, up 207.01% from the prior year.
• Exchange Rate Effect came in at -$8.4 million for Q1 2026 at West Pharmaceutical Services, down from -$500000.0 in the prior quarter.
• In the past five years, Exchange Rate Effect ranged from a high of $38.8 million in Q4 2022 to a low of -$24.1 million in Q3 2022.
• The 5-year median for Exchange Rate Effect is -$1.1 million (2024), against an average of -$352941.2.
• Across the five-year window, Exchange Rate Effect plunged 643.24% in 2022 and surged 1781.82% in 2025, its largest moves.
• West Pharmaceutical Services' Exchange Rate Effect stood at $38.8 million in 2022, then sank by 62.63% to $14.5 million in 2023, then tumbled by 256.55% to -$22.7 million in 2024, then surged by 97.8% to -$500000.0 in 2025, then plunged by 1580.0% to -$8.4 million in 2026.
• The last three Exchange Rate Effect figures came in at -$8.4 million (Q1 2026), -$500000.0 (Q4 2025), and -$3.6 million (Q3 2025), per Business Quant data.